What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests ...

After the emotional shock of a breast cancer recurrence, Teah decided to seek care – and proton therapy – at Fred Hutch ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that ...

Proton therapy is an advanced radiation treatment that precisely targets tumors with a goal of limiting harm to healthy tissue. It may help reduce short- and long-term side effects, lower the risk of ...

There's a growing interest in the use of bone-modifying agents, or BMAs, known as bisphosphonates in the cancer patient population. But these agents can cause short- and long-term side effects. What’s ...

A small observational study out of the U.K. of breast cancer patients found that certain types of chemotherapy can weaken part of the immune system for up to nine months after treatment.

There is much to consider when it comes to using the new semaglutide drugs for weight loss, especially for cancer patients. Fred Hutch experts weight in.

Far too many cancer patients face barriers to participating in clinical trials due to overly restrictive trial criteria. Here's how Fred Hutch researchers are changing that..

Here’s an equation to solve: What do you get when you add research jargon with statistics and multiply by the human brain’s tricks of perception? The answer, for many of us, is confusion. Statistics ...